Phloretin enhances adipocyte differentiation and adiponectin expression in 3T3-L1 cells

被引:111
作者
Hassan, Meryl
El Yazidi, Claire
Landrier, Jean-Francois
Lairon, Denis
Margotat, Alain
Amiot, Marie-Josephe
机构
[1] Univ Aix Marseille 2, INRA, Fac Med, INSERM 1260,UMR 476, F-13385 Marseille 5, France
[2] INSERM, U476, F-13385 Marseille, France
[3] Univ Aix Marseille 2, Fac Med, IPHM IFR 125, F-13385 Marseille, France
[4] ANDROS & Cie, F-46130 Biars Sur Cere, France
关键词
phloretin; flavonoid; 3T3-L1; adipocytes; adipocyte differentiation; PPAR gamma; C/EBP alpha; adiponectin; insulin resistance;
D O I
10.1016/j.bbrc.2007.07.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Adipocyte dysfunction is strongly associated with the development of cardiovascular risk factors and diabetes. It is accepted that the regulation of adipogenesis or adipokines expression, notably adiponectin, is able to prevent these disorders. In this report, we show that phloretin, a dietary flavonoid, enhances 3T3-L1 adipocyte differentiation as evidenced by increased triglyceride accumulation and GPDH activity. At a molecular level, mRNA expression levels of both PPAR gamma and C/EBP alpha, the master adipogenic transcription factors, are markedly increased by phloretin. Moreover, mRNA levels of PPAR gamma target genes such as LPL, aP2, CD36 and LXR alpha are up-regulated by phloretin. We also show that phloretin enhances the expression and secretion of adiponectin. Co-transfection studies suggest the induction of PPAR-gamma transcriptional activity as a possible mechanism underlying the phloretin-mediated effects. Taken together, these results suggest that phloretin may be beneficial for reducing insulin resistance through its potency to regulate adipocyte differentiation and function. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:208 / 213
页数:6
相关论文
共 24 条
[1]
Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S
[2]
Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach [J].
Bays, H ;
Mandarino, L ;
DeFronzo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) :463-478
[3]
Bioavailability of phloretin and phloridzin in rats [J].
Crespy, V ;
Aprikian, O ;
Morand, C ;
Besson, C ;
Manach, C ;
Demigné, C ;
Rémésy, C .
JOURNAL OF NUTRITION, 2001, 131 (12) :3227-3230
[4]
Transcriptional control of adipocyte formation [J].
Farmer, Stephen R. .
CELL METABOLISM, 2006, 4 (04) :263-273
[5]
Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation [J].
Fu, YC ;
Luo, NL ;
Klein, RL ;
Garvey, WT .
JOURNAL OF LIPID RESEARCH, 2005, 46 (07) :1369-1379
[6]
Detection of phloridzin in strawberries (Fragaria x ananassa Duch.) by HPLC-PDA-MS/MS and NMR spectroscopy [J].
Hilt, P ;
Schieber, A ;
Yildirim, C ;
Arnold, G ;
Klaiber, I ;
Conrad, J ;
Beifuss, U ;
Carle, R .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2003, 51 (10) :2896-2899
[7]
Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors [J].
Iwaki, M ;
Matsuda, M ;
Maeda, N ;
Funahashi, T ;
Matsuzawa, Y ;
Makishima, M ;
Shimomura, I .
DIABETES, 2003, 52 (07) :1655-1663
[8]
Synthesis and PPAR-γ ligand-binding activity of the new series of 2′-hydroxychalcone and thiazolidinedione derivatives [J].
Jung, SH ;
Park, SY ;
Kim-Pak, Y ;
Lee, HK ;
Park, KS ;
Shin, KH ;
Ohuchi, K ;
Shin, HK ;
Keum, SR ;
Lim, SS .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2006, 54 (03) :368-371
[9]
Adiponectin and adiponectin receptors [J].
Kadowaki, T ;
Yamauchi, T .
ENDOCRINE REVIEWS, 2005, 26 (03) :439-451
[10]
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome [J].
Kadowaki, Takashi ;
Yamauchi, Toshimasa ;
Kubota, Naoto ;
Hara, Kazuo ;
Ueki, Kohjiro ;
Tobe, Kazuyuki .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (07) :1784-1792